Oncology Information System
Oncology Information System market is segmented by players, region (country), by Type and by Appl ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Custom Oligonucleotides 1.2.3 Pre-designed Oligonucleotides 1.3 Market by End User 1.3.1 Global Oligonucleotide Synthesis Market Share by End User: 2017 VS 2021 VS 2028 1.3.2 Academic Research Institutes 1.3.3 Pharmaceutical and Biotechnology Companies 1.3.4 Diagnostic Laboratories 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Oligonucleotide Synthesis Market Perspective (2017-2028) 2.2 Oligonucleotide Synthesis Growth Trends by Region 2.2.1 Oligonucleotide Synthesis Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Oligonucleotide Synthesis Historic Market Size by Region (2017-2022) 2.2.3 Oligonucleotide Synthesis Forecasted Market Size by Region (2023-2028) 2.3 Oligonucleotide Synthesis Market Dynamics 2.3.1 Oligonucleotide Synthesis Industry Trends 2.3.2 Oligonucleotide Synthesis Market Drivers 2.3.3 Oligonucleotide Synthesis Market Challenges 2.3.4 Oligonucleotide Synthesis Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Oligonucleotide Synthesis Players by Revenue 3.1.1 Global Top Oligonucleotide Synthesis Players by Revenue (2017-2022) 3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Players (2017-2022) 3.2 Global Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Oligonucleotide Synthesis Revenue 3.4 Global Oligonucleotide Synthesis Market Concentration Ratio 3.4.1 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Synthesis Revenue in 2021 3.5 Oligonucleotide Synthesis Key Players Head office and Area Served 3.6 Key Players Oligonucleotide Synthesis Product Solution and Service 3.7 Date of Enter into Oligonucleotide Synthesis Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Oligonucleotide Synthesis Breakdown Data by Type 4.1 Global Oligonucleotide Synthesis Historic Market Size by Type (2017-2022) 4.2 Global Oligonucleotide Synthesis Forecasted Market Size by Type (2023-2028) 5 Oligonucleotide Synthesis Breakdown Data by End User 5.1 Global Oligonucleotide Synthesis Historic Market Size by End User (2017-2022) 5.2 Global Oligonucleotide Synthesis Forecasted Market Size by End User (2023-2028) 6 North America 6.1 North America Oligonucleotide Synthesis Market Size (2017-2028) 6.2 North America Oligonucleotide Synthesis Market Size by Country (2017-2022) 6.3 North America Oligonucleotide Synthesis Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Oligonucleotide Synthesis Market Size (2017-2028) 7.2 Europe Oligonucleotide Synthesis Market Size by Country (2017-2022) 7.3 Europe Oligonucleotide Synthesis Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Oligonucleotide Synthesis Market Size (2017-2028) 8.2 Asia-Pacific Oligonucleotide Synthesis Market Size by Country (2017-2022) 8.3 Asia-Pacific Oligonucleotide Synthesis Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Oligonucleotide Synthesis Market Size (2017-2028) 9.2 Latin America Oligonucleotide Synthesis Market Size by Country (2017-2022) 9.3 Latin America Oligonucleotide Synthesis Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Oligonucleotide Synthesis Market Size (2017-2028) 10.2 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2017-2022) 10.3 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Integrated DNA Technologies 11.1.1 Integrated DNA Technologies Company Detail 11.1.2 Integrated DNA Technologies Business Overview 11.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Introduction 11.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.1.5 Integrated DNA Technologies Recent Development 11.2 Merck 11.2.1 Merck Company Detail 11.2.2 Merck Business Overview 11.2.3 Merck Oligonucleotide Synthesis Introduction 11.2.4 Merck Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.2.5 Merck Recent Development 11.3 Eurofins Genomics 11.3.1 Eurofins Genomics Company Detail 11.3.2 Eurofins Genomics Business Overview 11.3.3 Eurofins Genomics Oligonucleotide Synthesis Introduction 11.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.3.5 Eurofins Genomics Recent Development 11.4 Thermo Fisher Scientific 11.4.1 Thermo Fisher Scientific Company Detail 11.4.2 Thermo Fisher Scientific Business Overview 11.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Introduction 11.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.4.5 Thermo Fisher Scientific Recent Development 11.5 Agilent Technologies 11.5.1 Agilent Technologies Company Detail 11.5.2 Agilent Technologies Business Overview 11.5.3 Agilent Technologies Oligonucleotide Synthesis Introduction 11.5.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.5.5 Agilent Technologies Recent Development 11.6 Eurogentec 11.6.1 Eurogentec Company Detail 11.6.2 Eurogentec Business Overview 11.6.3 Eurogentec Oligonucleotide Synthesis Introduction 11.6.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.6.5 Eurogentec Recent Development 11.7 GE Healthcare 11.7.1 GE Healthcare Company Detail 11.7.2 GE Healthcare Business Overview 11.7.3 GE Healthcare Oligonucleotide Synthesis Introduction 11.7.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.7.5 GE Healthcare Recent Development 11.8 LGC Biosearch Technologies 11.8.1 LGC Biosearch Technologies Company Detail 11.8.2 LGC Biosearch Technologies Business Overview 11.8.3 LGC Biosearch Technologies Oligonucleotide Synthesis Introduction 11.8.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.8.5 LGC Biosearch Technologies Recent Development 11.9 Nitto Denko Avecia 11.9.1 Nitto Denko Avecia Company Detail 11.9.2 Nitto Denko Avecia Business Overview 11.9.3 Nitto Denko Avecia Oligonucleotide Synthesis Introduction 11.9.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.9.5 Nitto Denko Avecia Recent Development 11.10 Genscript 11.10.1 Genscript Company Detail 11.10.2 Genscript Business Overview 11.10.3 Genscript Oligonucleotide Synthesis Introduction 11.10.4 Genscript Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.10.5 Genscript Recent Development 11.11 Genedesign 11.11.1 Genedesign Company Detail 11.11.2 Genedesign Business Overview 11.11.3 Genedesign Oligonucleotide Synthesis Introduction 11.11.4 Genedesign Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.11.5 Genedesign Recent Development 11.12 TriLink Biotechnologies 11.12.1 TriLink Biotechnologies Company Detail 11.12.2 TriLink Biotechnologies Business Overview 11.12.3 TriLink Biotechnologies Oligonucleotide Synthesis Introduction 11.12.4 TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.12.5 TriLink Biotechnologies Recent Development 11.13 Bio-Synthesis 11.13.1 Bio-Synthesis Company Detail 11.13.2 Bio-Synthesis Business Overview 11.13.3 Bio-Synthesis Oligonucleotide Synthesis Introduction 11.13.4 Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.13.5 Bio-Synthesis Recent Development 11.14 ATDBio 11.14.1 ATDBio Company Detail 11.14.2 ATDBio Business Overview 11.14.3 ATDBio Oligonucleotide Synthesis Introduction 11.14.4 ATDBio Revenue in Oligonucleotide Synthesis Business (2017-2022) 11.14.5 ATDBio Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Custom Oligonucleotides Table 3. Key Players of Pre-designed Oligonucleotides Table 4. Global Oligonucleotide Synthesis Market Size Growth by End User (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Oligonucleotide Synthesis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Oligonucleotide Synthesis Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Oligonucleotide Synthesis Market Share by Region (2017-2022) Table 8. Global Oligonucleotide Synthesis Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Oligonucleotide Synthesis Market Share by Region (2023-2028) Table 10. Oligonucleotide Synthesis Market Trends Table 11. Oligonucleotide Synthesis Market Drivers Table 12. Oligonucleotide Synthesis Market Challenges Table 13. Oligonucleotide Synthesis Market Restraints Table 14. Global Oligonucleotide Synthesis Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Oligonucleotide Synthesis Market Share by Players (2017-2022) Table 16. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2021) Table 17. Ranking of Global Top Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Oligonucleotide Synthesis Product Solution and Service Table 21. Date of Enter into Oligonucleotide Synthesis Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Oligonucleotide Synthesis Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Oligonucleotide Synthesis Revenue Market Share by Type (2017-2022) Table 25. Global Oligonucleotide Synthesis Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Oligonucleotide Synthesis Revenue Market Share by Type (2023-2028) Table 27. Global Oligonucleotide Synthesis Market Size by End User (2017-2022) & (US$ Million) Table 28. Global Oligonucleotide Synthesis Revenue Market Share by End User (2017-2022) Table 29. Global Oligonucleotide Synthesis Forecasted Market Size by End User (2023-2028) & (US$ Million) Table 30. Global Oligonucleotide Synthesis Revenue Market Share by End User (2023-2028) Table 31. North America Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million) Table 41. Integrated DNA Technologies Company Detail Table 42. Integrated DNA Technologies Business Overview Table 43. Integrated DNA Technologies Oligonucleotide Synthesis Product Table 44. Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 45. Integrated DNA Technologies Recent Development Table 46. Merck Company Detail Table 47. Merck Business Overview Table 48. Merck Oligonucleotide Synthesis Product Table 49. Merck Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 50. Merck Recent Development Table 51. Eurofins Genomics Company Detail Table 52. Eurofins Genomics Business Overview Table 53. Eurofins Genomics Oligonucleotide Synthesis Product Table 54. Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 55. Eurofins Genomics Recent Development Table 56. Thermo Fisher Scientific Company Detail Table 57. Thermo Fisher Scientific Business Overview Table 58. Thermo Fisher Scientific Oligonucleotide Synthesis Product Table 59. Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 60. Thermo Fisher Scientific Recent Development Table 61. Agilent Technologies Company Detail Table 62. Agilent Technologies Business Overview Table 63. Agilent Technologies Oligonucleotide Synthesis Product Table 64. Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 65. Agilent Technologies Recent Development Table 66. Eurogentec Company Detail Table 67. Eurogentec Business Overview Table 68. Eurogentec Oligonucleotide Synthesis Product Table 69. Eurogentec Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 70. Eurogentec Recent Development Table 71. GE Healthcare Company Detail Table 72. GE Healthcare Business Overview Table 73. GE Healthcare Oligonucleotide Synthesis Product Table 74. GE Healthcare Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 75. GE Healthcare Recent Development Table 76. LGC Biosearch Technologies Company Detail Table 77. LGC Biosearch Technologies Business Overview Table 78. LGC Biosearch Technologies Oligonucleotide Synthesis Product Table 79. LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 80. LGC Biosearch Technologies Recent Development Table 81. Nitto Denko Avecia Company Detail Table 82. Nitto Denko Avecia Business Overview Table 83. Nitto Denko Avecia Oligonucleotide Synthesis Product Table 84. Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 85. Nitto Denko Avecia Recent Development Table 86. Genscript Company Detail Table 87. Genscript Business Overview Table 88. Genscript Oligonucleotide Synthesis Product Table 89. Genscript Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 90. Genscript Recent Development Table 91. Genedesign Company Detail Table 92. Genedesign Business Overview Table 93. Genedesign Oligonucleotide SynthesisProduct Table 94. Genedesign Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 95. Genedesign Recent Development Table 96. TriLink Biotechnologies Company Detail Table 97. TriLink Biotechnologies Business Overview Table 98. TriLink Biotechnologies Oligonucleotide SynthesisProduct Table 99. TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 100. TriLink Biotechnologies Recent Development Table 101. Bio-Synthesis Company Detail Table 102. Bio-Synthesis Business Overview Table 103. Bio-Synthesis Oligonucleotide SynthesisProduct Table 104. Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 105. Bio-Synthesis Recent Development Table 106. ATDBio Company Detail Table 107. ATDBio Business Overview Table 108. ATDBio Oligonucleotide SynthesisProduct Table 109. ATDBio Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million) Table 110. ATDBio Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Oligonucleotide Synthesis Market Share by Type: 2021 VS 2028 Figure 2. Custom Oligonucleotides Features Figure 3. Pre-designed Oligonucleotides Features Figure 4. Global Oligonucleotide Synthesis Market Share by End User in 2021 & 2028 Figure 5. Academic Research Institutes Case Studies Figure 6. Pharmaceutical and Biotechnology Companies Case Studies Figure 7. Diagnostic Laboratories Case Studies Figure 8. Others Case Studies Figure 9. Oligonucleotide Synthesis Report Years Considered Figure 10. Global Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Oligonucleotide Synthesis Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Oligonucleotide Synthesis Market Share by Region: 2021 VS 2028 Figure 13. Global Oligonucleotide Synthesis Market Share by Players in 2021 Figure 14. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Oligonucleotide Synthesis Revenue in 2021 Figure 16. North America Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Oligonucleotide Synthesis Market Share by Country (2017-2028) Figure 18. United States Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Oligonucleotide Synthesis Market Share by Country (2017-2028) Figure 22. Germany Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Oligonucleotide Synthesis Market Share by Region (2017-2028) Figure 30. China Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Oligonucleotide Synthesis Market Share by Country (2017-2028) Figure 38. Mexico Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Oligonucleotide Synthesis Market Share by Country (2017-2028) Figure 42. Turkey Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 45. Merck Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 46. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 48. Agilent Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 49. Eurogentec Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 50. GE Healthcare Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 51. LGC Biosearch Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 52. Nitto Denko Avecia Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 53. Genscript Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 54. Genedesign Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 55. TriLink Biotechnologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 56. Bio-Synthesis Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 57. ATDBio Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed
Integrated DNA Technologies Merck Eurofins Genomics Thermo Fisher Scientific Agilent Technologies Eurogentec GE Healthcare LGC Biosearch Technologies Nitto Denko Avecia Genscript Genedesign TriLink Biotechnologies Bio-Synthesis ATDBio
Oncology Information System market is segmented by players, region (country), by Type and by Appl ... Read More
Oncology Nutrition market is segmented by players, region (country), by Type and by Application. ... Read More
Online Advertising market is segmented by players, region (country), by Format and by Application ... Read More
Open Source Services market is segmented by players, region (country), by Type and by Application ... Read More